← Leaderboards
Jeffrey D Lebensburger
University Of Alabama At Birmingham
$4,854,885
Attributed
$4,854,885
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2015–23$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,854,885 · 3
By mechanism
R01$3,789,939 · 1
K23$916,446 · 1
R03$148,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Aaron D Fobian$5,828,054
- Subhashini Bolisetty$2,440,861
- Bruce A Freeman$23,677,278
- Vishnu Anand Cuddapah$714,807
- Richard J. Whitley$15,110,969
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortChronic Kidney FailureChildhoodKidney DiseasesKidneyParticipantSickle Cell AnemiaPreventMonitorTherapeutic TrialsHigh PrevalenceBloodProspectiveMortalityDesignClinicMorbidity - Disease RateClinical TrialsPost Gamma-GlobulinsDialysis ProcedureTrainingHourChildFuture
Grant awards (14)
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$942,101
R01 · FY2023 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$200,030
R01 · FY2023 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$893,121
R01 · FY2022 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$691,063
R01 · FY2021 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$200,030
R01 · FY2021 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$107,440
R01 · FY2021 · HL · contact PI
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia$756,154
R01 · FY2020 · HL · contact PI
Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy$188,715
K23 · FY2019 · HL · contact PI
Acute Kidney Injury During Sickle Cell Crisis$74,250
R03 · FY2019 · HL · contact PI
Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy$191,145
K23 · FY2018 · HL · contact PI
Acute Kidney Injury During Sickle Cell Crisis$74,250
R03 · FY2018 · HL · contact PI
Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy$191,145
K23 · FY2017 · HL · contact PI
Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy$191,145
K23 · FY2016 · HL · contact PI
Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy$154,296
K23 · FY2015 · HL · contact PI